3 Pharmaceutical Stocks That Are Too Cheap to Ignore
On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities to get in on solid value stocks that are underpriced and offer solid dividends.
Viatris (NASDAQ: VTRS), (NYSE: GSK), and Organon (NYSE: OGN) are too inexpensive to pass up at this point. All three pharmaceutical stocks trade at under 7 times earnings and have forward price-to-earnings ratios of less than 10.
GSK PE Ratio data by YCharts.
Source Fool.com
GSK plc ADR Stock
€36.80
0.000%
With 6 Buy predictions and not the single Sell prediction the community is currently very high on GSK plc ADR.
With a target price of 49 € there is a positive potential of 33.15% for GSK plc ADR compared to the current price of 36.8 €.
